日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine

基于[18F]FDG PET/CT对接受伊匹木单抗和纳武利尤单抗+/- UV1端粒酶疫苗治疗的胸膜间皮瘤患者进行预后预测

Thunold, Solfrid; Hernes, Eivor; Farooqi, Saima; Öjlert, Åsa Kristina; Francis, Roslyn J; Nowak, Anna K; Szejniuk, Weronika Maria; Nielsen, Søren Steen; Cedres, Susana; Perdigo, Marc Simo; Sørensen, Jens Benn; Meltzer, Carin; Mikalsen, Lars Tore Gyland; Helland, Åslaug; Malinen, Eirik; Haakensen, Vilde Drageset

BAP1 Mutations and Pleural Mesothelioma: Genetic Insights, Clinical Implications, and Therapeutic Perspectives

BAP1 突变与胸膜间皮瘤:遗传学见解、临床意义和治疗前景

Cedres, Susana; Valdivia, Augusto; Priano, Ilaria; Rocha, Pedro; Iranzo, Patricia; Pardo, Nuria; Martinez-Marti, Alex; Felip, Enriqueta

Insights on Oligometastatic Non-Small-Cell Lung Cancer

寡转移性非小细胞肺癌的见解

Valdivia, Augusto; Mascaro-Baselga, Pau; Salva-de Torres, Clara; Geng-Cahuayme, Abraham; Torresan, Sara; Yaringaño, Jesus; Priano, Ilaria; Iranzo, Patricia; Pardo, Nuria; Masfarre, Laura; Mirallas, Oriol; Farfan, Karen; Cedres, Susana; Rocha, Pedro; Martinez-Marti, Alex; Felip, Enriqueta

Treatment patterns and humanistic burden of malignant pleural mesothelioma in Spain

西班牙恶性胸膜间皮瘤的治疗模式和人文负担

Cedres, Susana; Calvete, Julio; Taylor-Stokes, Gavin; Ayerza, Néstor Álvarez; Larena, David Vilanova; Daumont, Melinda

Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy

恶性胸膜间皮瘤的最新疗法及以免疫疗法为中心的未来治疗选择

Cedres, Susana; Valdivia, Augusto; Iranzo, Patricia; Callejo, Ana; Pardo, Nuria; Navarro, Alejandro; Martinez-Marti, Alex; Assaf-Pastrana, Juan David; Felip, Enriqueta; Garrido, Pilar

Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients.

恶性胸膜间皮瘤(MPM)患者配对样本中TILs的表达和基因表达模式

Cedres Susana, Serna Garazi, Gonzalez-Medina Alberto, Valdivia Augusto, Assaf-Pastrana Juan David, Iranzo Patricia, Callejo Ana, Pardo Nuria, Navarro Alejandro, Martinez-Marti Alex, Priano Ilaria, Fasani Roberta, Guardia Xavier, Gonzalo Javier, Carbonell Caterina, Frigola Joan, Amat Ramon, Navarro Victor, Dienstmann Rodrigo, Vivancos Ana, Nuciforo Paolo, Felip Enriqueta

High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC

染色体畸变水平高与非小细胞肺癌患者接受免疫检查点抑制剂治疗的获益呈负相关。

Frigola, Joan; Carbonell, Caterina; Irazno, Patricia; Pardo, Nuria; Callejo, Ana; Cedres, Susana; Martinez-Marti, Alex; Navarro, Alejandro; Soleda, Mireia; Jimenez, Jose; Hernandez-Losa, Javier; Vivancos, Ana; Felip, Enriqueta; Amat, Ramon

Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer

检查点抑制剂作用机制概述:免疫相关不良事件及其治疗对原发癌症进展的影响

Iranzo, Patricia; Callejo, Ana; Assaf, Juan David; Molina, Gaspar; Lopez, Daniel Esteban; Garcia-Illescas, David; Pardo, Nuria; Navarro, Alejandro; Martinez-Marti, Alex; Cedres, Susana; Carbonell, Caterina; Frigola, Joan; Amat, Ramon; Felip, Enriqueta

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma

NIPU:一项随机、开放标签的 II 期研究,评估纳武利尤单抗和伊匹木单抗联合 UV1 疫苗作为恶性间皮瘤患者二线治疗方案的疗效。

Haakensen, Vilde Drageset; Nowak, Anna K; Ellingsen, Espen Basmo; Farooqi, Saima Jamil; Bjaanæs, Maria Moksnes; Horndalsveen, Henrik; Mcculloch, Tine; Grundberg, Oscar; Cedres, Susana M; Helland, Åslaug

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer

一项随机、II期临床研究,旨在评估脱氧尿苷三磷酸酶抑制剂TAS-114联合S-1治疗晚期非小细胞肺癌患者的疗效,并与单独使用S-1进行比较。

Yamamoto, Nobuyuki; Hayashi, Hidetoshi; Planchard, David; Morán, Teresa; Gregorc, Vanesa; Dowell, Jonathan; Sakai, Hiroshi; Yoh, Kiyotaka; Nishio, Makoto; Cortot, Alexis B; Benhadji, Karim A; Soni, Nital; Huang, Jinhong; Makris, Lukas; Cedres, Susana